Cardiovascular complications in COVID-19.
Am J Emerg Med
; 38(7): 1504-1507, 2020 07.
Article
in English
| MEDLINE | ID: covidwho-912008
ABSTRACT
BACKGROUND:
The coronavirus disease of 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While systemic inflammation and pulmonary complications can result in significant morbidity and mortality, cardiovascular complications may also occur.OBJECTIVE:
This brief report evaluates cardiovascular complications in the setting of COVID-19 infection.DISCUSSION:
The current COVID-19 pandemic has resulted in over one million infected worldwide and thousands of death. The virus binds and enters through angiotensin-converting enzyme 2 (ACE2). COVID-19 can result in systemic inflammation, multiorgan dysfunction, and critical illness. The cardiovascular system is also affected, with complications including myocardial injury, myocarditis, acute myocardial infarction, heart failure, dysrhythmias, and venous thromboembolic events. Current therapies for COVID-19 may interact with cardiovascular medications.CONCLUSIONS:
Emergency clinicians should be aware of these cardiovascular complications when evaluating and managing the patient with COVID-19.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Cardiovascular Diseases
Type of study:
Experimental Studies
Limits:
Humans
Language:
English
Journal:
Am J Emerg Med
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS